⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9109447 | 0.79 | — | — | |
| SCHEMBL6028390 | 0.78 | — | — | |
| SCHEMBL195268 | 0.78 | — | — | |
| SCHEMBL845377 | 0.76 | — | — | |
| SCHEMBL22127296 | 0.75 | — | — | |
| Ethylene SCHEMBL6281181 | 0.74 | — | — | |
| SCHEMBL10739623 | 0.72 | — | — | |
| SCHEMBL28165354 | 0.72 | — | — | |
| SCHEMBL2287918 | 0.72 | — | — | |
| SCHEMBL10606161 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999051598-A1 | SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES: SELECTIVE NEUROPEPTIDE y RECEPTOR LIGANDS | NEUROGEN CORPORATION (US) | 1999-10-14 | — | — | WO | claimed |
| CN-111354974-A | High voltage stable copolymers for forming polymer electrolytes for lithium or sodium batteries | 罗伯特·博世有限公司 | 2020-06-30 | — | — | CN | disclosed |
| US-20200203763-A1 | HIGH-VOLTAGE STABLE COPOLYMER FOR CONSTITUTING A POLYMER ELECTROLYTE FOR A LITHIUM OR SODIUM CELL | ROBERT BOSCH GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
| US-8268825-B2 | Method for the treatment of anthrax infections | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2012-09-18 | — | — | US | disclosed |
| US-20100305119-A1 | Method for the treatment of anthrax infections | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-12-02 | — | — | US | disclosed |
| EP-0966464-B1 | SUBSTITUTED 2,4-DIAMINOPYRIMIDINES | BASILEA PHARMACEUTICA AG (CH) | 2003-05-28 | — | — | EP | disclosed |
| US-6114330-A | BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0966464-A1 | SUBSTITUTED 2,4-DIAMINOPYRIMIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998039328-A1 | SUBSTITUTED 2,4-DIAMINOPYRIMIDINES | F.HOFFMANN-LA ROCHE AG (CH) | 1998-09-11 | — | — | WO | disclosed |
| CN-1114834-A | antidiabetic agent | OTSUKA PHARMA CO LTD (JP) | 1996-01-10 | — | — | CN | disclosed |
| EP-0670831-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995009159-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-04-06 | — | — | WO | disclosed |
| US-4657579-A | HERBICIDE | SANDOZ LTD. (CH) | 1987-04-14 | — | — | US | disclosed |